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Blunt traumatic aortic transection: Endoluminal
repair with commercially available aortic cuffs
Albert Sam II, MD, Melina Kibbe, MD, Jon Matsumura, MD, and Mark K. Eskandari, MD,
Chicago, Ill
Blunt traumatic aortic transection remains a lethal condition. Treatment requires a high index of suspicion, prompt
diagnosis, and expedient operative repair. Even in the best of circumstances, morbidity and mortality associated with
open surgical repair are high, particularly because of frequent occurrence of other severe associated injuries. Endoluminal
aortic stent-graft repair is an accepted treatment option in patients with aneurysm degeneration, and may be an alternative
means of managing contained aortic transection. We describe three cases of blunt traumatic thoracic aortic transection
treated with commercially available aortic endoluminal stent grafts. (J Vasc Surg 2003;38:1132-5.)
Endoluminal repair of traumatic thoracic aortic tran-
section with a covered stent graft is an alternative means of
managing this lethal condition1-10 frequently found in the
patient with multiple injuries. Advantages of endoluminal
repair include no need for thoracotomy incision, aortic
cross-clamping, single lung ventilation, and systemic anti-
coagulation. We present our experience in treating three
blunt traumatic thoracic aortic transections with commer-
cially available aortic stent grafts without use of systemic
anticoagulation.
CASE REPORTS
Case 1. A 40-year-old morbidly obese woman was an unre-
strained passenger in a high-speed motor vehicle collision. A chest
computed tomography (CT) scan revealed intraluminal aortic
thrombus distal to the origin of the left subclavian artery (SCA).
The aorta at this level was 22 mm in maximal diameter. The patient
was transferred to our institution and taken to the operating room,
where a 6F sheath was inserted into the right common femoral
artery (CFA). An aortogram revealed an aortic transection on the
lesser curve of the aorta distal to the left SCA, with a loose, mobile
thrombus attached to an intimal flap and associated with extrava-
sation of contrast medium on the lesser curve (Fig 1, A). The
distance from the left SCA to the exit port of the 6F sheath was
greater than 55 cm, which was the length of the aortic cuff delivery
device (AneuRx; Medtronic/AVE, Santa Rosa, Calif); therefore
retroperitoneal access to the left external iliac artery was obtained.
A 6F sheath was inserted, followed by a 0.035-inch Amplatz super
stiff guide wire. A 26 mm  3.75 cm AneuRx aortic extender cuff
was advanced over the super stiff wire without a sheath and
deployed distal to the left SCA. An additional 28 mm  3.75 cm
AneuRx aortic cuff was deployed approximately 5 mm proximal to
the first cuff. A completion angiogram revealed complete exclusion
of the transection without compromised flow to the left SCA (Fig
1, B). A follow-up CT scan revealed good position of the en-
dografts and no extravasation.
Case 2. A 42-year-old man was the unrestrained driver in a
motor vehicle collision. Diagnostic peritoneal lavage was positive
for gross blood. After exploratory laparotomy, a chest CT scan
revealed a mediastinal hematoma, and an aortogram showed a
contained traumatic aortic disruption distal to the left SCA. The
patient was transferred to our institution, where CT scan measure-
ment of the aorta at the level of the left SCA was 22 mm in
diameter. The distance from the sternal notch to the right groin
crease was 66 cm. Retroperitoneal access to the left common iliac
artery was obtained, and an 8F sheath was inserted over a J-wire.
An arch aortogram demonstrated a contained transection of the
lesser curve of the descending aortic arch, approximately 1.5 cm
distal to the left SCA (Fig 2, A). Through an 18F 30 cm sheath
and over an 0.035-inch Amplatz super stiff guide wire, a 26 mm
3.3 cm proximal aortic cuff (Excluder; W. L. Gore & Associates,
Flagstaff, Ariz) was deployed beyond the origin of the left SCA (Fig
2, B). A completion angiogram revealed good placement of the
device, no extravasation, good apposition of the graft to the wall of
the aorta, and total injury exclusion (Fig 2, C). A CT scan of the
chest on postoperative day 7 revealed good position of the en-
dograft and no extravasation of contrast medium.
Case 3. A 40-year-old woman was the unrestrained passenger
in a high-speed motor vehicle collision. A CT scan of the chest
revealed traumatic aortic disruption on the lesser curve of the
descending thoracic aorta, associated with extravasation of contrast
medium, and a dissection extending 10 cm distal to the injury site.
CT scan measurement of the diameter of the aorta at the left SCA
was 20 mm (Fig 3, A). The distance from the sternal notch to the
right groin crease was 55 cm. In the operating room a 6F sheath
was inserted percutaneously into the right CFA. An arch aorto-
gram confirmed traumatic aortic disruption distal to the left SCA,
with periaortic extravasation and hematoma (Fig 3, B). After
advancing a 0.035-inch Amplatz super stiff guide wire, a 10F
percutaneous suture closure device (Perclose, Redwood City,
Calif) was advanced and deployed. An 18F  30 cm sheath was
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introduced into the right CFA, and a 28.5 mm 3.3-cm Excluder
proximal aortic extender cuff was deployed distal to the left SCA.
Three additional cuffs were required for adequate proximal (28.5
mm  3.3 cm) and distal exclusion of the transection and associ-
ated dissection (two, 26 mm  3.3 cm). A completion angiogram
revealed complete exclusion of the aortic injury, with no extrava-
sation and a patent left SCA (Fig 3, C). The right CFA was closed
with the previously deployed percutaneous sutures. A postopera-
tive CT scan revealed good position of the endografts, with no
extravasation.
DISCUSSION
Untreated traumatic thoracic aortic transection has an
estimated mortality of 85%10 and is the second leading cause
of death in patients who have sustained blunt trauma.11 When
feasible, historic treatment consists of management of associ-
ated injuries and blood pressure control in accord with either
expectant or delayed management. Even in ideal circum-
stances, standard emergent operative repair is associated with a
5% to 25% risk for paralysis and 20% to 30% mortality.10
Fig 1. Percutaneous diagnostic arch aortograms with digital subtraction imaging. A, Limited contrast medium
extravasation and intraluminal thrombus are seen along the lesser curve of proximal descending thoracic aorta. B,
Completion angiogram after deployment of two AneuRx aortic cuffs shows no extravasation and a patent left subclavian
artery.
Fig 2. Digital subtraction arch aortograms. A, Contained extravasation of contrast medium along the lesser curve of
the proximal descending thoracic aorta. An anomalous left vertebral artery arising from the aortic arch is also identified
proximal to the left subclavian artery. B, Positioning of the Excluder aortic cuff over the 0.035-inch wire before
deployment, proximal to the origin of the left subclavian artery. C, Completion angiogram shows no extravasation of
contrast medium and successful exclusion of the transection.
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Information on endoluminal stent-graft repair of trau-
matic aortic rupture is limited mainly to case reports or
small series in which investigational devices were used. In
these reports there appears to be a high technical success
rate and low procedure-related morbidity and mortality.
Our early experience is similar, with 100% technical success
and no procedure-related morbidity or death. Data on the
use of commercially available abdominal stent-graft devices
is represented previously by only a few reports.1-3 Off-label
use of an Food and Drug Administration–approved device
eliminates the challenges due to lack of availability, because
most active endovascular centers have multiple devices and
sizes in routine inventory stock. Hoffer et al1 reported
off-label use of commercially available abdominal aortic
stent grafts and cuffs for repair of thoracic aortic disrup-
tions, using the Ancure tube stent graft (26 mm  9 cm;
Guidant, Menlo Park, Calif) and the AneuRx cuff (22 mm
 3.75 cm; Medtronic/AVE). To our knowledge, ours is
the first report to describe use of the Excluder abdominal
aortic cuff (W. L. Gore & Associates) to treat thoracic aortic
disruption. One potential disadvantage of using devices not
designed for this indication is the short length of the graft.
When multiple cuffs are required to obtain seal, there is
only a 1.0 to 1.5 cm device overlap, which may become a
source of type III endoleak if the device migrates. Because
healing of the disruption will occur in most patients, we do
not believe this would pose a major problem. Close fol-
low-up is warranted to assess this potential complication.
The use of the Excluder cuff has several advantages over
the AneuRx device in treating blunt thoracic aortic tears.
The delivery system for the Excluder cuff is 61 cm long,
compared with 55 cm for the AneuRx device, potentially
enabling treatment of more patients with a percutaneous
CFA approach. The Excluder device has a flexible profile,
which places less radial friction along the aortic wall, en-
abling safer, more accurate device positioning. The Ex-
cluder delivery sheath is smaller (18F) than the AneuRx
sheath (21F). Finally, the rapid deployment system of the
Excluder eliminates the need for adjuncts to either arrest
the heart or lower the systemic blood pressure during
device deployment.
Most blunt thoracic aortic transections occur distal to
the left subclavian artery. A recent retrospective review of
50 angiograms obtained in patients with blunt thoracic
aortic transection revealed a mean length of injury along
the lesser curve of the aorta of 17 mm, and mean aortic
diameter of 19.3 mm.12 These authors also reported a
mean distance along the lesser aortic curve from the left
subclavian artery to the superior aspect of the injury of 5.6
mm. This would enable most such injuries to be adequately
treated with one or more aortic extender cuff devices. The
relatively short proximal neck has led to the recommenda-
tion that most tears will require coverage of the left SCA to
achieve adequate graft seal. This was not required in our
cases; however, we would not hesitate to exclude the left
SCA if required to adequately obtain proximal coverage of
the aortic disruption. This is important because the first
report of aortoesophageal fistula formation from a thoracic
graft infection has been presumed to be the result of
inadequate proximal seal and resultant type I endoleak.13
Fig 3. A, Chest computed tomography scan reveals a contained
transection of the proximal descending thoracic aorta, with sur-
rounding periadventitial hematoma and an associated intimal flap.
B, Digital subtraction fluoroscopic image of the aortic arch iden-
tifies the precise location of the contained transection. C, Comple-
tion aortogram shows total exclusion of the transection and pa-
tency of the left subclavian artery.
JOURNAL OF VASCULAR SURGERY
November 20031134 Sam et al
A proximal neck length of 10 to 20 mm is the current
recommended distance, on the basis of experience derived
with the Talent stent graft (Medtronic World Medical,
Sunrise, Fla) and Excluder TAG graft, used primarily for
exclusion of thoracic aneurysm. Traumatic aortic transec-
tion is a different disease process. First, most patients with
trauma do not have the typical atherosclerotic burden
noted in patients with aneurysm, and thus fixation of the
device is likely more reliable. In addition, because no aneu-
rysm is present, there is no region of reverse tapering, and
thus distal migration should be less likely than in the
aneurysmal thoracic aorta. For these reasons, when possi-
ble, we believe that one may safely deploy the device to
cover the injury without covering the left SCA. Long-term
follow-up of our patients will confirm whether our hypoth-
esis is accurate.
CONCLUSION
Commercially available aortic cuffs may be successfully
used in patients with blunt traumatic aortic transection.
The Excluder cuff has a flexible delivery profile, longer
sheath, and rapid deployment system, enabling greater ease
of deployment in this setting.
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